Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
Clinical trial NCT02877199 · COMPLETED
Trial details
- NCT number
- NCT02877199
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-04-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.